Novartis Share Price Borsa Italiana
Stocks
NOVN
CH0012005267
Pharmaceuticals
OTC Markets Traded|
Real-time Estimate
Tradegate
13:48:55 26/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 135.83 EUR | 0.00% |
|
-2.58% | +20.55% |
| 08-25 | Novartis AG : Gets a Buy rating from Deutsche Bank | ZD |
| 08-24 | Novartis slips, Oddo BHF still neutral |  |
| Market Cap | 304B 260B 244B 223B 421B 28,964B 425B 2,877B 1,120B 14,613B 1,141B 1,116B 48,393B | P/E 2026 * |
22.7x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 336B 288B 270B 247B 466B 32,079B 470B 3,187B 1,241B 16,185B 1,263B 1,236B 53,598B | EV / Sales 2026 * |
5.84x | EV / Sales 2027 * | 5.41x |
| Free-Float |
91.66% | Yield 2026 * |
2.73% | Yield 2027 * | 2.85% |
Last Transcript: Novartis
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 31/01/2018 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 15/03/2026 |
Karen Hale
CMP | Compliance Officer | 58 | 13/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 31/12/2014 |
| Director/Board Member | 69 | 31/12/2015 | |
Ton Büchner
BRD | Director/Board Member | 61 | 31/12/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -2.58% | - | - | 304B | |
| -1.06% | +0.65% | +77.42% | +122.82% | 1,100B | |
| +0.04% | +0.75% | +53.10% | +64.29% | 658B | |
| +0.48% | +2.65% | +28.06% | +81.19% | 470B | |
| -1.10% | +0.71% | +42.75% | +42.77% | 372B | |
| -0.71% | +0.30% | +25.89% | +40.95% | 304B | |
| -1.41% | +2.17% | +3.71% | +13.96% | 264B | |
| -0.36% | +3.99% | +53.31% | +72.49% | 239B | |
| -0.24% | +2.62% | -12.44% | -52.47% | 213B | |
| +1.38% | +3.72% | +30.33% | +93.56% | 184B | |
| Average | -0.18% | +3.01% | +33.57% | +53.29% | 422.54B | |
| Weighted average by Cap. | -0.06% | +2.21% | +45.67% | +71.26% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.65B 49.4B 46.29B 42.28B 79.79B 5,496B 80.58B 546B 213B 2,773B 216B 212B 9,183B | 61.31B 52.54B 49.23B 44.97B 84.86B 5,845B 85.7B 581B 226B 2,949B 230B 225B 9,766B |
| Net income | 13.95B 11.95B 11.2B 10.23B 19.31B 1,330B 19.5B 132B 51.44B 671B 52.38B 51.24B 2,222B | 15.5B 13.28B 12.45B 11.37B 21.46B 1,478B 21.67B 147B 57.16B 746B 58.21B 56.94B 2,469B |
| Net Debt | 32.68B 28B 26.24B 23.97B 45.23B 3,116B 45.68B 310B 120B 1,572B 123B 120B 5,205B | 27.82B 23.84B 22.34B 20.4B 38.5B 2,652B 38.88B 263B 103B 1,338B 104B 102B 4,431B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
